Trials / Sponsors / IVERIC bio, Inc.
IVERIC bio, Inc.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor) Geographic Atrophy, Macular Degeneration | Phase 3 | 2020-06-22 |
| Terminated | Safety Study of Zimura in Combination With Anti-VEGF Therapy in Patients With Neovascular AMD Neovascular Age-Related Macular Degeneration | Phase 2 | 2016-10-20 |
| Completed | Zimura in Participants With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration Geographic Atrophy, Dry Age-Related Macular Degeneration | Phase 2 / Phase 3 | 2015-12-15 |